article thumbnail

STAT+: Brazil dismisses antitrust complaint against Gilead over pricing for a hepatitis C drug

STAT

This purportedly contributed to nearly 6,000 deaths from the disease between 2015 and 2017, according to documents filed with the Administrative Council for Economic Defense. Continue to STAT+ to read the full story…

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

Of the cGMP letters, three major types of violations – deficiencies in process validation, documentation practices (data integrity) and quality control – accounted for 26 percent, 21 percent and 15 percent of warning letters respectively. Overall, validation, documentation and quality control were the major cGMP violations.

FDA 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ex-Merck & Co scientist accused of stealing trade secrets could face jail

pharmaphorum

In a document outlining the charges against Shafat Quadri, of North Potomac, Maryland the US Department of Justice (DoJ) referred only to “one of the largest pharmaceutical companies in the world” based in New Jersey.

article thumbnail

Envision acquire dDOC, hires Manish Goel as tech solutions head

pharmaphorum

Comms company Envision Pharma Group has acquired doDOC Corp, a document collaborative review, editing and authoring firm. doDOC enables simultaneous collaboration in the review, editing, and authoring of documents among multiple users.

article thumbnail

FDA drops PreCert report, new digital health guidances

pharmaphorum

A new final guidance document that dropped today updates a 2019 draft guidance and clarifies the categories of clinical decision support software that would not be regulated by FDA as a medical device. “I O’Leary said.

FDA 135
article thumbnail

Stop the Presses! DEA and DOJ Fine eBay for not Reporting Sales of Tableting and Pill Press Machines

The FDA Law Blog

In brief, in regard to proof of identity, the seller must obtain sufficient information to identify and document the identity of the purchaser. Thus, such persons are subject to identification, recordkeeping, and reporting requirements. Also, a DEA Form 452 report must be electronically filed within 15 days after the order is shipped.

article thumbnail

Novartis agrees $245m settlement over Exforge generics delay

pharmaphorum

The complaint claims that Par agreed not to launch its generic, in return for Novartis not launching a patent infringement suit and agreeing not to launch its own authorised generic of the drug until 30 March, 2015, giving Par a valuable six months to sell its generic unopposed in the market.